1,488
Views
22
CrossRef citations to date
0
Altmetric
Articles

Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance

, , , , , , , & show all
Pages 323-332 | Received 06 Feb 2017, Accepted 13 Mar 2017, Published online: 10 Apr 2017

Figures & data

Figure 1. Characteristics of KPAE. (A) Chemical structures of KDA and KPAE. (B) 1H NMR spectrum of KPAE in CDCl3. (C) GPC spectrum of KPAE in acid environment.

Figure 1. Characteristics of KPAE. (A) Chemical structures of KDA and KPAE. (B) 1H NMR spectrum of KPAE in CDCl3. (C) GPC spectrum of KPAE in acid environment.

Figure 2. Characteristic of EPI/siRNA-MEND. (A) TEM image. (B) Picture of agarose gel electrophoresis, channel 1-naked siRNA, Channel 2-EPI/siRNA-MEND. (C) Size distribution and Zeta potential distribution.

Figure 2. Characteristic of EPI/siRNA-MEND. (A) TEM image. (B) Picture of agarose gel electrophoresis, channel 1-naked siRNA, Channel 2-EPI/siRNA-MEND. (C) Size distribution and Zeta potential distribution.

Figure 3. HPLC chromatogram of MEND (A), EPI (B) and EPI-MEND (C).

Figure 3. HPLC chromatogram of MEND (A), EPI (B) and EPI-MEND (C).

Figure 4. In vitro cytotoxicity analysis.

Figure 4. In vitro cytotoxicity analysis.

Figure 5. Picture of cellular uptake experiment result.

Figure 5. Picture of cellular uptake experiment result.

Figure 6. Picture of endocytosis of MEND. (A) Location of FAM-siRNA-MEND (green). (B) Location of lysosome (blue). (C) Over lay of (A) and (B). (D) Location of EPI-MEND (red). (E) Location of cell nucleus (blue). (F) Over lay of (D) and (E).

Figure 6. Picture of endocytosis of MEND. (A) Location of FAM-siRNA-MEND (green). (B) Location of lysosome (blue). (C) Over lay of (A) and (B). (D) Location of EPI-MEND (red). (E) Location of cell nucleus (blue). (F) Over lay of (D) and (E).

Figure 7. Expression of P-gp in HepG2 cells. Top panel: images of P-gp expression with EPI. Bottom panel: representative western blot images of P-gp expression with different MEND.

Figure 7. Expression of P-gp in HepG2 cells. Top panel: images of P-gp expression with EPI. Bottom panel: representative western blot images of P-gp expression with different MEND.

Figure 8. Picture of in vivo distribution of MEND. (A) Distribution of Cy5-siRNA-MEND and EPI/Cy5-siRNA-MEND (excitation wavelength was 650 nm). (B) Distribution of EPI/Cy5-siRNA-MEND, free EPI and EPI-MEND (excitation wavelength was 480 nm). (C) Comparison of Cy5-siRNA fluorescence in the liver. (D) Comparison of EPI fluorescence in the liver.

Figure 8. Picture of in vivo distribution of MEND. (A) Distribution of Cy5-siRNA-MEND and EPI/Cy5-siRNA-MEND (excitation wavelength was 650 nm). (B) Distribution of EPI/Cy5-siRNA-MEND, free EPI and EPI-MEND (excitation wavelength was 480 nm). (C) Comparison of Cy5-siRNA fluorescence in the liver. (D) Comparison of EPI fluorescence in the liver.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.